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Objective: Primary care asthma management is often not compatible with national 
evidence-based guidelines. The objective of this study was to assess the feasibility and impact 
of the Asthma APGAR tools to enhance implementation of asthma guideline-compatible 
management in primary care practices.
Subjects: Twenty-four primary care practices across the US.
Methods: This is a mixed methods study. Quantitative data were used to assess changes in 
guideline recommended asthma management including use of daily controller therapy, planned 
care visits, and education and information documentation before and after implementation of 
the Asthma APGAR. Qualitative data from focus group sessions were used to assess health 
care professional and patient perceived usability and value of the Asthma APGAR tools during 
ofﬁ  ce visits for asthma.
Results: Implementing the Asthma APGAR tools in the 24 practices was associated with 
enhanced asthma visit-related medical record documentation including signiﬁ  cant increases 
in recording of activity limitations due to asthma and asthma symptom frequency, asthma 
medication nonadherence, asthma triggers, and the patients’ perceived response to therapy 
(p  0.01 for each item). Some care processes also increased signiﬁ  cantly including assessment 
of inhaler technique and prescribing of daily controller therapy among patients with persistent 
asthma. Focus groups of patients and of clinical staff reported that the Asthma APGAR tools 
were easy to use, “made sense” and “improved care” was given and received.
Conclusions: The Asthma APGAR tools are feasible to implement in primary care practices and 
their implementation is associated with increased guideline-compliant asthma management.
Keywords: asthma, guidelines, implementation, quality improvement, asthma control, mixed 
methods studies, qualitative research, primary care
Introduction
Asthma is a common chronic illness that results in signiﬁ  cant burden for patients, 
families, and the health care system as well as signiﬁ  cant preventable asthma 
morbidity and mortality (Yawn 2003; Savage-Brown et al 2005; Kelley et al 2005; 
Canino et al 2006; Yawn et al 2007). Among primary care practices, implementation of 
the national and international asthma guidelines has been shown to lower emergency 
health care resource utilization while improving patient outcomes (Bateman et al 2001, 
2002). However, several barriers continue to slow the implementation of asthma guide-
lines into daily primary care practice (Cabana et al 2000; Diette et al 2001; Finkelstein 
et al 2002) including failure to document some very basic asthma-related information. 
Basic information such as symptom frequency, frequency of missed or modiﬁ  ed activi-
ties due to those symptoms and information on triggers and therapy adherence appear 
in less than 40% of primary care medical record notes for asthma visits (Cabana et al 
2000, 2005; Yawn et al 2005; Yawn and Yawn 2005; Diette et al 2007). Without this 
basic information it is difﬁ  cult if not impossible to assess the effectiveness of current Journal of Asthma and Allergy 2008:1 2
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asthma control or reasons for failure to achieve asthma 
control (Vollmer 2004; Stoloff and Boushey 2006; Yawn 
et al 2006).
Some tools have been developed that facilitate collection 
of symptoms, activity, and use of rescue medications 
(Juniper et al 1999; Vollmer et al 2002; Nathan et al 2004; 
Skinner et al 2004; Quality Metrics 2005; Pinnock et al 2005; 
Michele & Amegavie 2005; Lenoir et al 2006; EPR Update 
2007; Schatz et al 2006, 2007). While helpful in determining 
the level of control, these tools do not collect the crucial infor-
mation required to identify potential reasons for poor control: 
trigger exposure, lack of adherence to prescribed therapy, and 
patient failure to see value in their asthma therapy.
The Asthma APGAR was developed specifically to 
improve implementation of asthma guidelines in family 
medicine practices. The Asthma APGAR tools include a 
patient survey to collect the same information on found 
on control scores but adds patient reported information on 
asthma triggers, adherence to prescribed medications, and 
the patient’s perception of asthma relief from therapy. The 
cueing is intended to help physicians move beyond medica-
tion management to comprehensive asthma management. 
The second part of the Asthma APGAR is an asthma man-
agement algorithm that incorporates recommendations for 
asthma education, dealing with patient adherence to therapy, 
assessing and teaching proper inhaler technique, and employ-
ing follow-up visits for monitoring of asthma management 
as outlined in the 2007 NHLBI asthma guidelines (EPR 
Update 2007). The Asthma APGAR tools were developed 
by the authors in collaboration with practicing primary care 
physicians (Yawn 2004) thereby assuring that the tools are 
practical and have face validity for primary care physicians 
(Figures 1 and 2).
This study presents data on the feasibility and impact of 
implementation of the Asthma APGAR tools in a network 
of primary care practices with emphasis on the processes of 
asthma management. The combination of qualitative and 
quantitative methodology allows the asthma care process 
results to be put in the context of patient and health care pro-
fessional perceptions of the value of these tools in everyday 
asthma care.
Methods
This is a mixed methods study completed in US community 
based primary care practices (Westfall et al 2007). 
Quantitative data from medical record review were 
supplemented by qualitative data from patient and from 
health care professional focus groups.
After receiving approval from the Institutional Review 
Board of the Olmsted Medical Center and all 24 sites 
involved in the study, the Asthma APGAR tools were 
introduced into each of the 24 practices. The process was led 
by a physician/nurse team from each practice who attended 
a six hour training session (either face to face or by tele-
phone conference call) during which the development and 
intended use of Asthma APGAR tools were explained. The 
tools of the Asthma APGAR include a practice assessment 
(Table 1), a patient (parent) completed Asthma APGAR 
survey (Figure 1), and the Asthma APGAR care algorithm 
(Figure 2). Attendees were given an update on asthma 
management based on asthma control and suggestions on 
how to introduce the Asthma APGAR tools to their practice 
colleagues.
Within each enrolled practice, the lead physician and 
nurse completed the practice self-assessment by reviewing 
the medical records of 15 people who had been seen for an 
asthma visit (a visit with 493.xx as the ﬁ  rst diagnostic code) 
during the previous six months. The records were reviewed 
from the date of most recent asthma visit retrospectively to 
identify documentation of the Asthma APGAR elements 
(Table 1). Review of multiple visits was allowed since not all 
information may be recorded at a single visit. This relatively 
simple practice self-assessment was used to help motivate 
the practice by providing information on current asthma care 
and gaps in that care suggested by the audit elements (Cabana 
et al 2005; Diette et al 2007; Solberg 2007).
In each practice, the lead physician and nurse used their 
practice’s audit data to facilitate an all-practice discussion of 
apparent strengths and gaps in current asthma management. 
Each of the practices agreed that data currently recorded in 
the medical record was inadequate to determine the level 
of asthma control. Furthermore, without knowing what the 
patient was actually taking (versus what was prescribed), and 
information on triggers, it was not possible to know how to 
modify currently used asthma therapies.
Based on identiﬁ  ed practice gaps, review of the new asthma 
guidelines and introduction of the Asthma APGAR tools, each 
practice agreed to try implementing the Asthma APGAR tools 
as a practice change stimulus. During any identiﬁ  ed asthma 
visit the patient (parent) would complete the Asthma APGAR 
survey that would be scored and linked to the care algorithm 
to direct asthma management. Speciﬁ  cally the frequency of 
daytime symptoms, the frequency of nighttime symptoms and 
the frequency of missed or modiﬁ  ed activities as reported by the 
patient (parent) are each scored with a 0, 1, or 2 and then totaled 
(Figure 1). Any total score of 2 or greater (possible range 0 to 6) Journal of Asthma and Allergy 2008:1 3
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is consistent with “inadequate control” and directs the physician 
to the left side of the care management algorithm (Figure 2). For 
scores of 0 and 1, the user is directed to the “adequate control” or 
right side of the care algorithm. Both sides address issues such 
as inhaler technique demonstration and observation, asthma 
education and planned care visits, eg, follow-up visits at times 
other than during an exacerbation. The inadequate control side 
also includes assessment of adherence, trigger knowledge, and 
avoidance plus possible changes in medication therapy.
Both quantitative and qualitative data were collected to 
assess the impact of the Asthma APGAR tools. Quantitative 
data were collected from medical record review by experienced 
research nurse abstractors from the central site and included all 
the Asthma APGAR elements (Table 1) plus information on the 
presence of documentation regarding assessment or demonstra-
tion of inhaler technique, notation of any asthma education or 
of a nonacute asthma visit (planned care visit). Adherence was 
considered use of at least of 80% of the doses of prescribed 
Asthma APGAR
R = Response to therapy
A = Asthma medications
G = triGGers
Please circle your answers:
P = Persistent
A = Activities
A
P
G
A
R
Never
None
None
Yes
Cigarettes Smoke Colds
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Seldom
Worse A Lot Better A Little Better No Different
Daily As needed
As needed
As needed
As needed
Daily
Daily
Daily
6. When I use my breathing or asthma medicines I feel:
When taken? Reasons for taking
medication:
Reasons for not
taking medication:
Breathing or
Asthma Medication
5.    List or describe medications you’ve taken for breathing problems or asthma in
the past 2 weeks: Remember you may use Nasal, Oral, or Inhaler medications.
Sometimes Most of the times
• Can you avoid the things that make your breathing problems or asthma
      wores?
Cats Dogs Mold Other: Flowers
Dust Dust Mites Exercise Cold Air
• Please circle things that make your breathing problems or asthma worse:
No Unsure
sleeping due to coughing, shortness of breath, wheezing, chest tightness or get up to
use your rescue medication?
in the past 2 weeks did you have shortness of
in the past 2 weeks did you wake up or have trouble
2.    How many DAYS 
4. Do you know what makes your breathing problems or asthma worse? 
3.    How many NIGHTS
breath, wheezing, chest tightness, cough or felt you should use your rescue inhaler?
3 or more times
3 or more DAYS
3 or more NIGHTS
1 – 2 times
1 – 2 DAYS
1 – 2 NIGHTS
1.   In the past 2 weeks, how many times did any breathing problems (such as
asthma) interfere with your ACTIVITIES or activities you wanted to do?
P = Asthma Plan
U = Use of inhaler
S = Steroids
L = Lung function
Figure 1 Asthma APGAR – patient questions.Journal of Asthma and Allergy 2008:1 4
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medications being reported as taken. Data were collected from 
40 patients per practice, 20 before, and another 20 nine months 
after Asthma APGAR implementation, half of which were 
children less than age 16. This data collection was completely 
separate from the practice audits done by the lead physician and 
nurse at each site. Patients were selected randomly from a list 
of all those making asthma visits in the six months prior to the 
review. The same patients were not used for before and after 
assessment since people make only 1.2 asthma visits per year 
on average (Yawn et al 2007) and therefore only the patients 
with the most severe asthma are likely to be seen during both 
the before and the after period of this study. Including only these 
patients would likely result in selection bias for more severe or 
more difﬁ  cult to control cases of asthma.
Seven sites, selected for the greatest geographic 
(Pennsylvania, Washington State, Connecticut, 
and Minnesota) and practice type diversity (single and 
multi-specialty rural and suburban sites), held two focus 
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groups per site (one with patients and one with health 
professionals) to supplement the quantitative information. 
Topics discussed in the focus groups included Asthma 
APGAR readability, ease of answering, as well as perceived 
relevance and value for the patient’s asthma care. A complete 
list of the focus group questions is available from the authors. 
Focus groups were led by two of the authors: BY took notes 
and SB asked the questions. For the patient focus group, the 
two authors were introduced as interested parties but not as 
the study principal investigator and study coordinator.
The Asthma APGAR practice assessment tools and patient 
survey were developed by one of the authors (BY) based on 
her previous research and the work of others that included 
the review of hundreds of medical record notations from 
asthma visits written by primary care physicians (Yawn 2004; 
Yawn et al 2007). The care management algorithm is based on 
information from existing national and international asthma 
guidelines (NAEPP and GINA) as well as in-depth review 
of the asthma management literature. Prior to the initiation 
of this study, several community-based family physicians 
reviewed, tested, and modiﬁ  ed the Asthma APGAR tools 
used in this study (Yawn 2004).
To assess continued use of the Asthma APGAR system 
after study completion, we called all 24 sites to ask the lead 
physician, lead nurse, or the nursing supervisor whether the 
Asthma APGAR was still being used in practice. All follow-up 
was done at least 24 months after completion of the study.
Data analysis
Very simple statistical assessment was done to simulate 
what might be available for practice quality improvement 
activities. The before and after audit data were compared 
using Chi-squared statistics for each site, but are presented 
in aggregate since the direction and relative size of change 
were the same for all practices. Rates of change in the use 
of controller medications was based only on the care of 
the patients whose medical recorded were used to collect 
the “after” data. Current use of controller medication was 
compared to use of a controller medication at the latest visit 
made prior the practice’s implementation of the Asthma 
APGAR tools.
Qualitative data were analyzed using the editing method 
with both BY and SB reviewing all focus group data and 
identifying themes from each group and then for all patient 
groups and all health professional groups collectively 
(Crabtree 1999).
Results
The 24 sites that participated in this study included 
194 physicians plus 17 other clinicians. All but 5 practices 
were single specialty family medicine practices (Table 2). 
From the 24 sites, the medical records of 840 people with 
asthma were audited for baseline or before data and the 
medical records of 851 people with asthma were audited 
nine months following implementation of the Asthma 
APGAR.
Comparison of the before and after medical record 
documentation data is shown in Figure 3. Improvement 
occurred in all areas of medical record documentation that 
were assessed. For example, from the aggregate assessment, 
documentation of activity modification due to asthma 
increased by 100% from 29% to 58%, symptom frequency 
Table 1 Asthma APGAR practice audit questions
Asthma APGAR Tool for practice assessment score: For each question:   Y = yes present, N = not documented, and U = unsure.
1. Activity: Was the number of missed activity days in the past 2 wks noted?
Y         N     U
2. Persistence
a. Was the number of days with symptoms in the past 2 wks noted?
Y       N        U
b. Was the number of nights with symptoms in the past 2 wks noted?
Y       N        U
3. TriGGers: Were triggers noted as being discussed?
Y       N        U
4. Adherence to asthma medications: Were the type and frequency of asthma medications taken in the past 2 weeks noted?
Y       N        U
5. Response to therapy: Was the patient’s response to therapy noted?
Y     N       UJournal of Asthma and Allergy 2008:1 6
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documentation increased by 30% from 62% to 81%, and 
nighttime symptom frequency documentation increased by 
152% from 25% to 63%. Documentation of nonsymptom 
issues also increased by large relative percents; trigger 
information by 167% from 30% to 80%, adherence by 200% 
from 31% to 93%, and comments on response to therapy 
increased by 71% from 49% to 84%. Patient’s answers to one 
or more of the Asthma APGAR questions were speciﬁ  cally 
mentioned in an average of 81% (689 of 851) of the “after” 
medical records reviewed.
Other process measures also suggest increased 
compliance with asthma guidelines. The prescribing of 
a daily antiinﬂ  ammatory medication increased by 204% 
from 24% before use of the Asthma APGAR tools to 
73% after (p  0.001). Documentation of nurse or physi-
cian observation of patient’s inhaler technique increased 
Table 2 Demographics of clinics, and clinician health professionals
Clinic size
N = 24
 n Type of clinic
 N = 24 
n MD N NP/PA N Location (States)  N Male Clinicians % Average 
age Yrs.
3 MDs 3
One specialty
Multispecialty
13
11
MN 20
3 to 8 MDs 16 PA 1
9 to 15 MDs 3 194 17 WA 1 74 47
15 MDs 2 IL 1 range
WI 1 (28–68)
Abbreviations: MD, medical doctor; IL, Illinois; MN, Minnesota; PA, Pennsylvania;   WA, Washington;  WI, Wisconsin.
Asthma APGAR
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p<0.001
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Pre-intervention (n=840) Post-Intervention (n=851) (n = 840)
 p < 0.001  p < 0.01  p < 0.001  p < 0.001  p < 0.001
 p < 0.001
Figure 3 Histogram for before and after documentation of asthma information in the medical records.Journal of Asthma and Allergy 2008:1 7
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by 145% from 22% before to 54% after Asthma APGAR 
implementation (p = 0.001). The percent of patients who 
had a nonurgent asthma care visit in the six months prior 
to medical record abstraction increased by 425%, from 4% 
in the “before” to 21% after (p  0.001). Medical record 
documentation of asthma education increased by 575% 
from 8% before to 54% after (p  0.0001) introduction 
of the Asthma APGAR tools.
The seven health professional focus groups (one per site) 
were attended by a total of 72 staff members, including 
physicians (n = 38), nurses (n = 8), medical assistants (n = 20), 
receptionists (n = 4), and clinic administrators (n = 2). A total 
of 71 patients and parents attended the seven patient focus 
groups including eight child patient-parent pairs and two 
spouse-patient pairs.
During the focus groups health professional comments 
regarding the Asthma APGAR centered around 3 themes; 
ease of use, value of the information, and efﬁ  ciency of 
asthma visits. Physicians that used the system (78% of all 
eligible) reported that when the patient completed the Asthma 
APGAR, it captured all of the preliminary data they needed 
for asthma assessment, and thereby streamlined the visit. The 
visit time could be used to ask more detailed questions, or 
provide education or develop solutions related to problems 
such as frequent symptoms, poor adherence, or newly 
identiﬁ  ed triggers. Overall the health professionals felt that 
the Asthma APGAR tools saved time and improved the qual-
ity of the asthma visit. Physicians said that they usually scored 
the APGAR and usually followed the medication portion of 
the algorithm. The nurses used the portion of the algorithm 
related to adherence, especially the reminders about assess-
ing inhaler technique, asking about asthma education needs, 
and making referrals to asthma education resources. Nursing 
staff often used the patient questionnaire sheet to facilitate 
recording asthma medications in the medical record by 
documenting what the patient was actually taking rather 
than what had been prescribed. Receptionists reported that 
they usually gave the patients the Asthma APGAR survey to 
complete and that patients who had received the questions 
during a previous visit sometimes ask for the “asthma” sheet 
when they came for their next asthma visit.
The physicians in the practices either initially liked and 
used the Asthma APGAR system regularly (78%, n = 56 
[all within practices]) or refused to even consider using 
the system (22%, n = 16 [physicians]). Those physicians 
initially refusing to use the APGAR system did attend the 
last review of the progress before study completion and 
after hearing the responses of their physician colleagues to 
the beneﬁ  t and limited time burden for use of the APGAR, 
12 of the 16 said they would like to try using the Asthma 
APGAR. They were especially interested in its time-saving 
aspects.
Patient comments during the focus groups also centered 
on three domains; providing new information to their phy-
sician (speciﬁ  cally information about triggers, symptom 
frequency, and lack of adherence), improving self-efﬁ  cacy 
(taking charge of asthma visit and self assessment), and 
receiving better care. The patients and parents reported 
that the Asthma APGAR patient questionnaire was easy to 
complete, requiring 5 minutes or less. None of the patient 
attendees had problems reading the Asthma APGAR 
questions and all agreed that the questions made sense. 
Several attendees noted that the Asthma APGAR questions 
covered topics they had not previously discussed with their 
physician or nurse, especially frequency of problems, adher-
ence, and triggers. Patients reported that they did not mind 
completing the form at each asthma visit since asthma prob-
lems changed from visit to visit. Three attendees reported that 
they and their physicians had identiﬁ  ed new asthma triggers 
after completing the Asthma APGAR. One attendee stated 
that completing the Asthma APGAR was the ﬁ  rst time she 
had told her doctor she could not afford her medications and 
was not getting her prescriptions ﬁ  lled. She was able to apply 
for a medication support program at that visit. A mother said 
that the Asthma APGAR allowed her 8-year-old daughter to 
begin to take responsibility for her asthma when they took 
a copy home to use as part of her asthma action plan. Three 
adult attendees from different sites reported that they used the 
Asthma APGAR at home and felt they were now in control 
of their asthma.
Discussion
Use of the Asthma APGAR was associated with enhanced 
documentation in medical record notations for asthma visits 
and increased prescribing of daily controller medications, 
inhaler technique education and nonurgent asthma visits. 
In this “before” and “after” study design, it is not possible 
to demonstrate that the practice changes were due to use 
of the Asthma APGAR tools. However, the consistency in 
the direction and size of the practice change, the temporal 
relation to implementation of the Asthma APGAR tools and 
the much larger than expected change in asthma process 
measures suggests that at least part of the practice change is 
associated with the Asthma APGAR (Bateman et al 2001; 
Finkelstein et al 2002; Sin et al 2004; Mangione-Smith et al 
2005; Wroth and Boals 2005).Journal of Asthma and Allergy 2008:1 8
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Increasing medical records documentation is an 
important practice change. Without documentation of the 
asthma data assessed in this study, health professionals are 
unable to determine levels of asthma control or to select 
appropriate next steps in asthma management (Diette et al 
2001; Fuhlbrigge 2004; Cabana et al 2005; Yawn et al 
2005; Stoloff and Boushey 2006; EPR Update 2007; GINA 
Guidelines 2008). The Asthma APGAR also facilitated col-
lection of information that could inﬂ  uence levels of control. 
The increase in the prescribing of daily controller medica-
tions suggests that documentation and use of the Asthma 
APGAR tools was associated with increased compliance 
with guideline recommended care. Other primary care 
investigators have also identiﬁ  ed the importance of using 
the patient perspective in assessing asthma control (Horne 
et al 2007). In addition, focus group responses from both 
health professionals and patients reported Asthma APGAR 
provided more information then usually obtained during an 
asthma care visit.
Since the Asthma APGAR is intended as a practice change 
and guideline implementation tool, its value was assessed by 
usability, perceived value, and impact on the delivery of guide-
line compliant asthma care. This type of in-practice validation 
is most appropriate for implementation tools as opposed to 
assessment tools that require a different type of validation and 
different outcome measures. In-practice evaluation should be 
required of all practice implementation tools before they are 
recommended for widespread use in primary care.
By providing information on triggers and medication 
adherence, the Asthma APGAR can and did appear to facili-
tate exploration of factors known to affect control (Wark et al 
2001; Weiss et al 2001; Mo et al 2003; EPR Update 2007). 
Adherence to medical therapy is a major problem in asthma 
(Fiese et al 2005; Bender 2006; Horne 2006; Marceau et al 
2006). By asking patients to record exactly what they are 
currently using, physicians or nurses can focus on solutions 
rather than adherence assessment that may be perceived as 
confrontational or judgmental (Wark et al 2001; Yawn 2003; 
Horne 2006). In the focus group sessions patients reported 
that including a place to explain deviations from prescribed 
medication allowed them to be honest with the physician and 
nurse while focusing on problem solving rather than incrimi-
nations. Future studies need to assess whether documenting 
this information results in improving adherence rates.
Others have also suggested the importance of asking 
patients about their perception of response to current asthma 
therapy could facilitate discussion and education related 
to the important and speciﬁ  c role of each type of therapy 
(Horne et al 2007). Two of the focus group attendees stated 
that this question led to clariﬁ  cation of which medication 
was to be used for quick relief and which was the antiin-
ﬂ  ammatory medication for longer term control (Boushey 
et al 2005; EPR Update 2007). Both patients and staff 
reported that the Asthma APGAR questions helped the 
patient feel “more like a partner instead of a patient” for 
asthma management.
The Asthma APGAR care management flow sheet 
combines aspects from many different sections of the 2007 
NHLBI asthma guidelines: assessment, monitoring, educa-
tion, and treatment as well as medication step therapy (EPR 
Update 2007). The Asthma APGAR care algorithm recom-
mends adherence assessment, trigger avoidance assessment, 
inhaler technique review, asthma education, and when 
needed, objective lung function testing in conjunction with 
the medication management.
Our results must be viewed in the context of the study’s 
limitations. No direct patient outcomes were collected and 
the sites that participated volunteered to do so. It is possible 
that other sites that were less interested would have less 
change in the process measures evaluated. Currently no 
studies report successful methods to work with practices 
that have no interest in care improvement. All of the physi-
cians and most of the patients included in this study were 
Caucasian, so that it is not possible to know if the Asthma 
APGAR is useful in more racially diverse practices. The 
attendees at the focus groups may not be representative of 
all socioeconomic groups within practices although 25% of 
all attendees reported that they had some type of insurance 
that included government support. Future studies must assess 
the impact of the Asthma APGAR on longer term patient 
outcomes. It is these measures rather than comparison with 
expert opinion, lung function, or future health care utiliza-
tion that will justify use of the Asthma APGAR tools in 
primary care practice. While we did include medical record 
conﬁ  rmed episodes of asthma education, prescribing of 
controller medications to patients with persistent asthma 
and active review of inhaler technique, we did not include 
other measures of asthma care that are not discussed in the 
patient survey or in the care algorithm. We have only self-
reports to conﬁ  rm that 22 of the 24 practices continued to 
use all or part of the Asthma APGAR system 24 months 
after completion of the study.
Implementation of the Asthma APGAR tools was feasible 
in diverse types of primary care practices, was associated 
with changes in asthma care, and was reported to be accept-
able and valuable by patients and health care professionals. Journal of Asthma and Allergy 2008:1 9
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In these practices, the Asthma APGAR tools became the basis 
of an asthma chronic care system motivated by a practice 
self-assessment and facilitated by use of tools developed in 
primary care to enhance asthma care content and activate 
patients.
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